SOP defines a method to assess cytotoxicity of compounds using a luminescence-based assay in laboratory settings.
This Standard Operating Procedure (SOP) defines the method for evaluating the cytotoxicity of test compounds within the AVITHRAPID project using a luminescence-based cell viability assay.
No takes yet. Share an insight, caveat, or question.
Ilenia Varasi (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: